Prescription Drugs

Prescription Drug Materials

• Poll: Seniors Would Cross Party Lines to Vote for Candidates Who Support Medicare Drug Price Negotiation

  August 03, 2021: More than 70 percent of voters over age 65 say they would be more likely to vote for a candidate who favors allowing Medicare to negotiate with drug corporations to lower prescription drug prices, including strong majorities acros Read More >

• President Biden Signs Executive Order Targeting High Drug Prices

  July 19, 2021: Last Friday, President Biden signed an executive order to address high drug prices while Congress works on legislation to allow Medicare to negotiate lower prices for prescription drugs. The executive order: Authorizes fed Read More >

• Report Shows Top 14 Drug Corporations Could Easily Afford Medicare Price Negotiation

  July 12, 2021: On Thursday, Rep. Carolyn Maloney (NY), the Chairwoman of the House Committee on Oversight and Reform, held a press conference with Speaker Nancy Pelosi (CA) to release a new report analyzing the finances of 14 of the world’s la Read More >

• New Report Details Patient Advocacy Groups’ Reliance on Big Pharma Donations

  July 06, 2021: An explosive new report by Patients For Affordable Drugs found that fifteen prominent patient advocacy groups, including groups that focus on specific diseases or conditions, have taken millions of dollars from drug corporations a Read More >

• Retiree Organization Urges Congress to Lower Drug Prices Now; Older Americans are “Fed Up”

  June 22, 2021: Statement from Richard Fiesta, executive director of the Alliance for Retired Americans, on the Senate Finance Committee’s Principles for Drug Pricing Reform: “Americans continue to pay the highest prices in the world for p Read More >

• Government Panel: Higher Drug Prices, not More Prescriptions, Are Driving Higher Medicare Spending

  June 21, 2021: Medicare’s spending on prescription drugs increased by 26% between 2013 and 2018 -- and high drug prices are to blame -- according to a new report from the Medicare Advisory Payment Commission (MedPAC). The expert report rebu Read More >

• Drug Prices Rose at Twice the Inflation Rate in 2020

  June 15, 2021: Leading House Democrats this week said they'll try to incorporate the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) — the bill that allows Medicare to directly negotiate reduced medication costs — into whatever infrastr Read More >

• Hearing Exposes Greed of Drug Corporation AbbVie

  May 24, 2021: According to a study released on May 18 by the U.S. House Oversight and Reform Committee, the pharmaceutical corporation AbbVie has raised prices 470% in the United States for its widely used drugs Humira and Imbruvica over the pa Read More >

• Mounting Evidence Demonstrates Need for Action on High Drug Prices

  May 11, 2021: As the House Energy and Commerce Subcommittee on Health held a hearing on a bill requiring Medicare to negotiate lower drug prices, a new report found that the pharmaceutical industry spent $92 million on lobbying Congress during Read More >

• Fact Sheet: Pandemic Treatment Access and Affordability (PTAA) Act

  April 26, 2021: The federal government has spent tens of billions of taxpayer dollars on research and development (R&D) of vaccines and treatments for COVID-19, including $23 billion for manufacturing and purchasing. Despite this public inves Read More >